tDCS for Cancer-Related Fatigue and Weakness
Starting soon · Early Phase 1 · Has a placebo group
Conditions studied: Cancer-related Fatigue, Neuromodulation
In brief
This pilot study investigates the effectiveness of non-invasive brain stimulation (tDCS) in alleviating cancer-related fatigue (CRF) and muscle weakness. Using a randomized, double-blind crossover design, participants perform fatiguing muscle tasks with and without tDCS, and outcomes include task endurance, maximal voluntary contraction force, and neuromuscular markers. Neural mechanisms will be assessed via EEG, TMS, and MRI.
Key facts
- Study ID
- NCT07159100
- Run by
- Kessler Foundation
- People needed
- 75
- Starts
- 2025-09-10
- Expected to finish
- 2027-12-31
- Last updated by the study team
- 2025-09-08
Who can join
Age: 40 and older, up to 80. Sex: any. Healthy volunteers: accepted.
Where it is running
- Kessler Foundation — West Orange, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.